Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.

Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.

We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...

Descripció completa

Dades bibliogràfiques
Autors principals:	Antoniades, C, Lee, R, Kohler, M, Stradling, J
Format:	Journal article
Idioma:	English
Publicat:	European Respiratory Society 2016

Ítems similars

Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress
per: Turnbull, C, et al.
Publicat: (2016)

The effects of CPAP withdrawal in patients with OSA on hypoxia-induced markers
per: Turnbull, C, et al.
Publicat: (2016)

Effect of CPAP withdrawal on myocardial perfusion in OSA - a randomized controlled trial
per: Schwarz, E, et al.
Publicat: (2016)

Blood pressure variability in OSA – data from four randomised-controlled CPAP-withdrawal trials
per: Lettau, F, et al.
Publicat: (2017)

Effect of CPAP-withdrawal on blood pressure in OSA: data from three randomized-controlled trials
per: Schwarz, E, et al.
Publicat: (2016)

Residual sleepiness in patients with OSA on CPAP.
per: Stradling, JR
Publicat: (2009)

Effects of Overnight Supplemental Oxygen on Morning Blood Pressure in a Randomized Controlled CPAP Withdrawal Trial in Patients with OSA
per: Petousi, N, et al.
Publicat: (2018)

CPAP and measures of cardiovascular risk in males with OSAS.
per: Kohler, M, et al.
Publicat: (2008)

Patterns of CPAP usage in patients with minimally symptomatic OSA
per: Turnbull, C, et al.
Publicat: (2015)

In minimally symptomatic OSA what is the best test to measure CPAP response?
per: Turnbull, C, et al.
Publicat: (2015)

CPAP increases bronchial reactivity in OSAS patients
per: P. Korczyski, et al.
Publicat: (2008-06-01)

Relative accuracy of algorithm-based prescription of nasal CPAP in OSA.
per: Stradling, JR, et al.
Publicat: (2004)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
per: Tang, I, et al.
Publicat: (2020)

EFFECT OF CPAP TREATMENT FOR OSA ON VISUAL PROCESSING OF DEGRADED WORDS
per: Proudlove, K, et al.
Publicat: (2012)

Return of sleep apnoea and sleep fragmentation following CPAP withdrawal in patients with obstructive sleep apnoea
per: Turnbull, C, et al.
Publicat: (2019)

A novel, simplified approach to starting nasal CPAP therapy in OSA.
per: Stradling, JR, et al.
Publicat: (2004)

In patients with minimally symptomatic OSA can baseline characteristics and early patterns of CPAP usage predict those who are likely to be longer-term users of CPAP
per: Turnbull, CD, et al.
Publicat: (2016)

Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
per: John R Stradling, et al.
Publicat: (2020-09-01)

COVID-19 related changes in outpatient CPAP set-up pathways for OSA are linked with decreased 30-day CPAP usage
per: Turnbull, CD, et al.
Publicat: (2021)

Effect of CPAP on depressive symptoms in OSA
per: Samy S. Eldahdouh, et al.
Publicat: (2014-04-01)

Baseline blood pressure and hypersomnolence predict bp fall with CPAP treatment of OSA
per: Robinson, G, et al.
Publicat: (2007)

CPAP IMPROVES ENDOTHELIAL FUNCTION IN MINIMALLY SYMPTOMATIC OSA PATIENTS: RESULTS FROM THE MOSAIC TRIAL
per: Kohler, M, et al.
Publicat: (2010)

Circulating Superoxide Dismutase Concentrations in Obstructive Sleep Apnoea (OSA): A Systematic Review and Meta-Analysis
per: Maria Carmina Pau, et al.
Publicat: (2021-11-01)

Physiological consequences of CPAP therapy withdrawal in patients with obstructive sleep apnoea-An opportunity for an efficient experimental model
per: Schwarz, E, et al.
Publicat: (2018)

The effects of supplemental oxygen on blood pressure in obstructive sleep apnoea during cpap withdrawal
per: Turnbull, C, et al.
Publicat: (2017)

Transcriptomic analysis identifies a unique, intermittent hypoxia mediated inflammatory profile: evidence from a cross-over randomised CPAP withdrawal trial, with and without supplemental oxygen, in OSA
per: Turnbull, C, et al.
Publicat: (2018)

Superoxide dismutase kinetics.
per: Falconi, M, et al.
Publicat: (2002)

Blood pressure variability with and without supplemental oxygen during CPAP withdrawal
per: Ercan, S, et al.
Publicat: (2022)

THE PRIMARY RESULTS OF THE MOSAIC TRIAL: DOES CPAP FOR MINIMALLY SYMPTOMATIC OSA REDUCE DAYTIME SLEEPINESS OR CALCULATED VASCULAR RISK?
per: Craig, SE, et al.
Publicat: (2010)

Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?
per: Turnbull, C, et al.
Publicat: (2015)

CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial.
per: Kohler, M, et al.
Publicat: (2013)

Decreased erythrocyte superoxide dismutase in elderly men with early nuclear cataract
per: Rose, et al.
Publicat: (2014-04-01)

Effect of CPAP on cardiac function in minimally symptomatic patients with OSA: results from a subset of the MOSAIC randomized trial
per: Craig, S, et al.
Publicat: (2015)

Paradoxical relationship between Mn superoxide dismutase deficiency and radiation-induced cognitive defects.
per: Rikki Corniola, et al.
Publicat: (2012-01-01)

Neonatal Extracellular Superoxide Dismutase Knockout Mice Increase Total Superoxide Dismutase Activity and VEGF Expression after Chronic Hyperoxia
per: Maxwell Mathias, et al.
Publicat: (2021-08-01)

Overnight urinary isoprostanes as a marker of oxidative stress in obstructive sleep apnoea
per: Turnbull, C, et al.
Publicat: (2017)

CHANGE IN SLEEP STUDY AND CPAP PROVISION FOLLOWING THE NIHCE CPAP TA
per: Hill, G, et al.
Publicat: (2012)

Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA
per: Craig, S, et al.
Publicat: (2014)

EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) ON DIURNAL SODIUM AND WATER-EXCRETION IN OBSTRUCTIVE SLEEP-APNEA (OSA)
per: Warley, A, et al.
Publicat: (1987)

Effect of supplemental oxygen on blood pressure in obstructive sleep apnea (SOX): A randomised, CPAP withdrawal trial
per: Turnbull, C, et al.
Publicat: (2019)